GLP-1 Weight Loss and Diabetes Medications Linked to Reduced Risk of Substance Use Disorders
St. Louis—A comprehensive new study has revealed that GLP-1 receptor agonists, blockbuster drugs widely known for treating diabetes and obesity, … Read more